[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-380398-105":59,"doc-detail-380398-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","routine-prophylactic-percutaneous-endoscopic-gastrostomy-in-head-and-neck-cancers-with-bilateral-neck-irradiation-a-regional-cancer-experience-in-new-zealand","Routine Prophylactic Percutaneous Endoscopic Gastrostomy in Head and Neck Cancers with Bilateral Neck Irradiation - A Regional Cancer Experience in New Zealand","","Head and neck cancer patients are highly prone to dysphagia and malnutrition, and prophylactic percutaneous endoscopic gastrostomy (PEG) practices vary across institutions. This regional study reviews nutritional and PEG-related outcomes for radiotherapy patients receiving treatment to primary and bilateral neck regions at Midcentral District Health Board. Records from 49 patients were assessed for weight loss, non-elective hospitalisation, treatment interruption, PEG complications, utilisation, dependency, and late dysphagia outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/routine-prophylactic-percutaneous-endoscopic-gastrostomy-in-head-and-neck-cancers-with-bilateral-neck-irradiation-a-regional-cancer-experience-in-new-zealand/380398/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/routine-prophylactic-percutaneous-endoscopic-gastrostomy-in-head-and-neck-cancers-with-bilateral-neck-irradiation-a-regional-cancer-experience-in-new-zealand/380398.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-24",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study?","Question",{"text":113,"@type":114},"To review nutritional outcomes and PEG-related outcomes for patients receiving radiotherapy to the primary and bilateral neck regions, including weight loss, non-elective hospitalisation, and treatment interruption rates.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were patients selected and what study design was used?",{"text":118,"@type":114},"A retrospective review of medical records was conducted for 49 patients with biopsy-proven head and neck cancer treated with radical radiotherapy at Palmerston North Hospital between 1 January 2010 and 31 December 2016.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key findings related to PEG safety and outcomes?",{"text":122,"@type":114},"Prophylactic PEG placement showed relatively safe results, with high utilisation and no reported PEG-related mortality. Complications occurred, most commonly peristomal infection, and long-term dependency was generally low after treatment completion.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},380398,1790531883,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","ORIGINAL ARTICLE  \nRoutine Prophylactic Percutaneous Endoscopic Gastrostomyin Head and Neck Cancers with Bilateral Neck Irradiation: A Regional Cancer Experience in New Zealand  \nSu Chen Fong, MB, BCh, BAO (Hons), FRANZCR 1 , Ramesh Pandey, (MBBS Hons), BTech (Hons), MS, FRANZCR 1,2, Michelle Rajaretnam, MB, BCh, BAO (Hons) 1,  \nMiriama Delaibatiki, MBCHB, PGDipOMG, FRANZCR 1,3, & David N.Y. Peel, MB, ChB, FRCR 1  \n1Department of Radiation Oncology, Palmerston North Hospital, Midcentral DHB, Palmerston North, New Zealand 2Department of Radiation Oncology, Auckland Hospital, Auckland, New Zealand  \n3Department of Radiation Oncology, Kathleen Kilgour Centre, Tauranga Hospital, Tauranga, New Zealand  \nKeywords  \nDysphagia, gastrostomy, hospitalisation, squamous cell carcinoma of head and neck, weight loss  \nCorrespondence  \nSu Chen Fong, Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia. Tel:  \n+61394969803; Fax: +61394962826; E-mail:  \n[fongsc.ro3@gmail.com](fongsc.ro3@gmail.com)  \nReceived: 3 November 2022; Accepted: 15 June 2023  \nJ Med Radiat Sci 70 (2023) 292–300  \ndoi: 10.1002/jmrs.699  \nAbstract  \nIntroduction: Patients with head and neck cancer (HNC) are particularly susceptible to dysphagia and malnutrition. Prophylactic percutaneous endoscopic gastrostomy (PEG) placement is a method used to manage these issues, but practices vary among institutions. At Midcentral District Health Board, patients receiving radiotherapy to the primary and bilateral neck regions routinely undergo prophylactic PEG placement. This study aimed to review the nutritional and PEG-related outcomes of these patients. Methods: Records of 49 patients were retrospectively reviewed. Their demographics, tumour and treatment characteristics were recorded. We evaluated patient weight loss, nonelective hospitalisation, treatment interruption rates, PEG-related complications, usage, dependency rates and late dysphagia rates. Results: Oropharyngeal cancers were the most common primary site (61.2%), and 83.7% of patients received primary chemoradiotherapy. Mean weight loss at treatment completion was 5.6% 􀀁 4.3 (4.6 kg 􀀁 3.9) . The rate of non-elective hospitalisations was 26.5%, and only 2% of patients had treatment interruptions. Peristomal infection was the most frequent PEG complication (20.4%) . No PEG-related mortality was reported. Median duration of PEG dependency was 97 days (14–388 days) . Two patients remained permanently dependent at 3 years due to grade 3 dysphagia, and six patients experienced grade ≥2 late dysphagia. Conclusion: Our study showed that prophylactic PEG tube placement was relatively safe, with a high utilisation rate and low longterm dependence on PEG tubes after treatment completion. However, complications related to their use should be addressed through a multidisciplinary approach, with careful assessment by clinicians. The weight loss and hospitalisation rates observed were consistent with earlier studies that utilised prophylactic PEG tubes.  \nIntroduction  \nUp to 57% of head and neck (HNC) patients have markedly impaired nutritional status at the time of diagnosis and prior to treatment commencement. 1,2 Multiple interventions have been introduced to reduce  \nthe impact of treatment toxicities on patients including dietary counselling and nutritional support. Whenever feasible, enteral route is preferred for nutritional support, as patients with HNC often have a functioning gastrointestinal tract.3 While nasogastric (NG) tube feeding used to be the method of choice, percutaneous  \n292 ª 2023 The Authors. Journal of Medical Radiation Sciences published by John Wiley & Sons Australia, Ltd on behalf of Australian Society of Medical Imaging and Radiation Therapy and New Zealand Institute of Medical Radiation Technology.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use","cbCaim1hCoqrczl5","https://ap.wps.com/l/cbCaim1hCoqrczl5","pdf",279218,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To review nutritional outcomes and PEG-related outcomes for patients receiving radiotherapy to the primary and bilateral neck regions, including weight loss, non-elective hospitalisation, and treatment interruption rates.\"},{\"question\":\"How were patients selected and what study design was used?\",\"answer\":\"A retrospective review of medical records was conducted for 49 patients with biopsy-proven head and neck cancer treated with radical radiotherapy at Palmerston North Hospital between 1 January 2010 and 31 December 2016.\"},{\"question\":\"What were the key findings related to PEG safety and outcomes?\",\"answer\":\"Prophylactic PEG placement showed relatively safe results, with high utilisation and no reported PEG-related mortality. Complications occurred, most commonly peristomal infection, and long-term dependency was generally low after treatment completion.\"}]","Routine Prophylactic Percutaneous Endoscopic Gastrostomy in Head and Neck Cancers with Bilateral Neck Irradiation - A Regional Cancer Experience in New Zealand | PDF",1790240029,23]